CRISPRi screening identifies PIKfyve as a co-therapeutic target for obinutuzumab

8 107

Cited 0 times in

DC Field	Value	Language
dc.contributor.author	김주영	-
dc.contributor.author	이동혁	-
dc.date.accessioned	2025-07-17T03:07:35Z	-
dc.date.available	2025-07-17T03:07:35Z	-
dc.date.issued	2025-05	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/206586	-
dc.description.statementOfResponsibility	open	-
dc.format	application/pdf	-
dc.language	English	-
dc.publisher	Wiley	-
dc.relation.isPartOf	CLINICAL AND TRANSLATIONAL MEDICINE	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	CRISPRi screening identifies PIKfyve as a co-therapeutic target for obinutuzumab	-
dc.type	Article	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Dept. of Pharmacology (약리학교실)	-
dc.contributor.googleauthor	Yerim Kim	-
dc.contributor.googleauthor	Jinkyung Oh	-
dc.contributor.googleauthor	Jeong Ryeol Kim	-
dc.contributor.googleauthor	Donghyuk Lee	-
dc.contributor.googleauthor	Joo Young Kim	-
dc.identifier.doi	10.1002/ctm2.70333	-
dc.contributor.localId	A00942	-
dc.relation.journalcode	J04026	-
dc.identifier.eissn	2001-1326	-
dc.identifier.pmid	40342289	-
dc.contributor.alternativeName	Kim, Joo Young	-
dc.contributor.affiliatedAuthor	김주영	-
dc.citation.volume	15	-
dc.citation.number	5	-
dc.citation.startPage	e70333	-
dc.identifier.bibliographicCitation	CLINICAL AND TRANSLATIONAL MEDICINE, Vol.15(5) : e70333, 2025-05	-

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers

Show simple item record Find it @ YMLIB

YUHSpace: CRISPRi screening identifies PIKfyve as a co-therapeutic target for obinutuzumab